Skip to main content
. Author manuscript; available in PMC: 2017 Dec 11.
Published in final edited form as: J Infect Dis. 2017 Nov 27;216(9):1104–1111. doi: 10.1093/infdis/jix455

Table 1.

Rhinovirus Detections in Acute-Phase Serum (n) and Corresponding Nasopharyngeal/Oropharyngeal Specimens (N) Among 570 Rhinovirus-Positive Community-Acquired Pneumonia Patients by Age Group and Rhinovirus Species

Age group RV-A RV-B RV-C Total RV
n/N (%)



n/N (%) n/N (%) n/N (%)
<6 mo 0/27 (0.0) 0/4 (0.0) 2/20 (10.0) 2/51 (3.9)

6–11 mo 0/25 (0.0) 0/2 (0.0) 5/28 (17.9)a 5/55 (9.1)

12–23 mo 1/25 (4.0) 0/3 (0.0) 20/52 (38.5) 21/80 (26.3)

24–59 mo 0/38 (0.0) 0/2 (0.0) 20/58 (34.5) 20/98 (20.4)

5–9 y 0/31 (0.0) 0/7 (0.0) 9/53 (17.0) 9/91 (9.9)

10–17 y 0/28 (0.0) 0/2 (0.0) 0/11 (0.0) 0/41 (0.0)

≥18 y 0/104 (0.0) 0/19 (0.0) 0/31 (0.0) 0/154 (0.0)

Total 1/278 (0.4) 0/39 (0.0) 56/253 (22.1) 57/570 (10.0)

Abbreviations: RV, rhinovirus.

a

RV-C detected in the serum of 1 patient, and RV-A detected in the corresponding respiratory specimen.